May 2018

Here's a recap of recent blog posts and other news.

After a great deal of work, we are pleased to announce details of two new publications, which are linked to from this RxISK blog post.

1. A paper in the International Journal of Risk & Safety in Medicine, entitled  Enduring sexual dysfunction after treatment with antidepressants: 300 cases.  In 2014, we were the first group to publish details in the medical literature about persistent sexual dysfunction after using isotretinoin. Our new paper once again includes this problem. In fact, isotretinoin was the single most commonly reported drug in our study.

2. We have also put together a  petition to the FDA requesting changes to SSRI and SNRI product labels to warn about post-SSRI sexual dysfunction and persistent genital arousal disorder. The petition sets out in detail the nature of the problem, the history of the conditions, and what needs to be done about it.

In case you missed it, see the The New York Times article Many People Taking Antidepressants Discover They Cannot Quit which quotes RxISK's Dr. Derelie Mangin:  "The truth is that the state of the science is absolutely inadequate... We don't have enough information about what antidepressant withdrawal entails, so we can't design proper tapering approaches."

Thank you for your support. 
Your feedback, as always, is greatly appreciated.
David Healy Signature (First Name)  

David Healy, MD

PS. You can  follow RxISK on  Facebook  and  Twitter .

RxISK Blog

A recent email to RxISK on the topic of antidepressant withdrawal brings out the fact that bupropion withdrawal is very different from SSRI withdrawal and both are very different to mirtazapine withdrawal.  Email from Edge My name is A.  I'm 28. I was prescribed to Wellbutrin 3 years ago, and took it for 18 [...] ...»

A feature article in the New York Times recently by Ben Carey covered dependence on and withdrawal from antidepressants.  Here. It led to over a thousand comments within 48 hours including a predictable set of comments from doctors claiming that antidepressants don't cause dependence and that any problems they do cause are readily manageable. It [...]...»


The picture here shows the before and after feet of a person who has erythromelalgia. After exercise or in response to other triggers, sometimes just lying in bed, the feet or other body parts can become hot and burning, possibly painfully so. The condition is linked to sodium channels. Those who get it may have [...]...»

Dr. David Healy
David Healy's Blog

Medwatcher Japan recently convened a symposium on the injuries caused by Human Papilloma Virus (HPV) Vaccines.  Medwatcher are one of the most impressive pharmacovigilance groups in the world today. The statement from the meeting, issued just as Hanami (cherry-blossom) season ends, again notes the injuries gratuitously inflicted by bureaucrats and others - in this [...] ...»

By most accounts Jose Mario Bergolio is a remarkable person. It came as a shock to his fans then a few months ago when he visiting Chile he came out against victims of child abuse.  The issue centered on one bishop whom survivors of abuse fingered as complicit with what had happened.  JMB obviously liked [...]...»

Last week's post - 18 percent - raised questions about company sponsorship and seeming patient empowerment websites.  A comment by Johanna Ryan afterwards kicked off this follow-up post. Johnson & Johnson gave NAMI $340,000 last year, and $540,000 in 2016. https://www.nami.org/getattachment/About-NAMI/Our-Finances/Major-Foundation-Corporate-Sponsorships/WebRegistryQ42017.pdf Part of that was a dedicated $100,000 grant for "First Episode Psychosis." This is [...]...»

From: Zach Schleien <zach.s@18percent.org> Date: 19 March 2018 at 04:00 Subject: I Started a Slack Group for Mental Illness To: David Healy Hi David, Here's a story I think would be perfect for David Healy: When one of my closest friends took his own life after his battle with schizophrenia, I resolved to do something constructive for [...]...»